Maryland Senate and House / 2026 Regular Session

HB0484: Corporate Income Tax - Addition Modification - Direct-to-Consumer Pharmaceutical Advertising

In the House - Hearing 2/12 at 1:00 p.m.

Providing an addition modification under the corporate income tax for the amount of certain direct-to-consumer advertising expenses for certain covered drugs paid or incurred during the taxable year that are deducted under the Internal Revenue Code; and applying the Act to all taxable years beginning after December 31, 2025.

Official bill page · Source: Maryland General Assembly

Ask about HB0484

Legislative actions

No action history has been imported for this bill. This does not mean the bill had no actions.

Raw source record
{
    "Title": "Corporate Income Tax - Addition Modification - Direct-to-Consumer Pharmaceutical Advertising",
    "Status": "In the House - Hearing 2\/12 at 1:00 p.m.",
    "BillType": "Regular",
    "Sponsors": [
        {
            "Name": "Delegate Ziegler"
        },
        {
            "Name": "Delegate Feldmark"
        },
        {
            "Name": "Delegate Terrasa"
        },
        {
            "Name": "Delegate Addison"
        },
        {
            "Name": "Delegate Charkoudian"
        },
        {
            "Name": "Delegate Cullison"
        },
        {
            "Name": "Delegate Ebersole"
        },
        {
            "Name": "Delegate Guzzone"
        },
        {
            "Name": "Delegate Hill"
        },
        {
            "Name": "Delegate Moreno"
        },
        {
            "Name": "Delegate Watson"
        }
    ],
    "Statutes": [
        {
            "Article": {
                "Code": "gtg",
                "Title": "Tax - General"
            },
            "Sections": [
                {
                    "Section": "10-305"
                }
            ]
        }
    ],
    "Synopsis": "Providing an addition modification under the corporate income tax for the amount of certain direct-to-consumer advertising expenses for certain covered drugs paid or incurred during the taxable year that are deducted under the Internal Revenue Code; and applying the Act to all taxable years beginning after December 31, 2025.",
    "BillNumber": "HB0484",
    "BillVersion": "F",
    "PassedByMGA": false,
    "BroadSubjects": [
        {
            "Code": "q3",
            "Name": "Taxes - Income"
        },
        {
            "Code": "j1",
            "Name": "Public Health"
        }
    ],
    "ChapterNumber": "",
    "EmergencyBill": false,
    "NarrowSubjects": [
        {
            "Code": "advertising",
            "Name": "Advertising"
        },
        {
            "Code": "commerb",
            "Name": "Commerce and Business -see also- ElectrComm; ForeignTr; etc."
        },
        {
            "Code": "corporations",
            "Name": "Corporations -see also- Municipal Corps; Public Corps & Inst"
        },
        {
            "Code": "drugs",
            "Name": "Drugs -see also- Cannabis; ControlDangSubst; Pharm; etc."
        },
        {
            "Code": "electrcom",
            "Name": "Electronic Communication"
        },
        {
            "Code": "exemptions",
            "Name": "Exemptions"
        },
        {
            "Code": "incomet",
            "Name": "Income Tax"
        },
        {
            "Code": "industm",
            "Name": "Industry and Manufacturing"
        },
        {
            "Code": "internet",
            "Name": "Internet -see also- Internet Access"
        },
        {
            "Code": "mobiled",
            "Name": "Mobile Devices"
        },
        {
            "Code": "postals",
            "Name": "Postal Service"
        },
        {
            "Code": "radio",
            "Name": "Radio"
        },
        {
            "Code": "signsb",
            "Name": "Signs and Billboards"
        },
        {
            "Code": "socialm",
            "Name": "Social Media"
        },
        {
            "Code": "telecommunica",
            "Name": "Telecommunications"
        },
        {
            "Code": "telephones",
            "Name": "Telephones"
        },
        {
            "Code": "television",
            "Name": "Television -see also- Cable Television"
        }
    ],
    "SponsorPrimary": "Delegate Ziegler",
    "YearAndSession": "2026 Regular Session",
    "StatusCurrentAsOf": "2026-11-13T11:57:19.330",
    "CrossfileBillNumber": "",
    "CommitteePrimaryOrigin": "Ways and Means",
    "ConstitutionalAmendment": false,
    "ReportDateHouseOfOrigin": null,
    "ReportDateOppositeHouse": null,
    "CommitteePrimaryOpposite": "",
    "CommitteeSecondaryOrigin": "",
    "ReportActionHouseOfOrigin": "",
    "ReportActionOppositeHouse": "",
    "CommitteeSecondaryOpposite": "",
    "InteractionBetweenChambers": "",
    "FirstReadingDateHouseOfOrigin": "2026-01-23",
    "FirstReadingDateOppositeHouse": null,
    "ThirdReadingDateHouseOfOrigin": null,
    "ThirdReadingDateOppositeHouse": null,
    "SecondReadingDateHouseOfOrigin": null,
    "SecondReadingDateOppositeHouse": null,
    "ThirdReadingActionHouseOfOrigin": "",
    "ThirdReadingActionOppositeHouse": "",
    "SecondReadingActionHouseOfOrigin": "",
    "SecondReadingActionOppositeHouse": "",
    "HearingDateTimePrimaryHouseOfOrigin": "2026-02-12T13:00:00",
    "HearingDateTimePrimaryOppositeHouse": null,
    "HearingDateTimeSecondaryHouseOfOrigin": null,
    "HearingDateTimeSecondaryOppositeHouse": null
}